Exploración integral de la enfermedad de Huntington en Juan de Acosta, Colombia: perspectivas históricas, neuropsicológicas, genéticas y neuroanatómicas

datacite.rightshttp://purl.org/coar/access_right/c_16ec
dc.contributor.advisorAcosta, Johan
dc.contributor.authorAhmad, Mostapha
dc.date.accessioned2024-04-25T13:35:41Z
dc.date.available2024-04-25T13:35:41Z
dc.date.issued2024
dc.description.abstractLa presente tesis ofrece un análisis exhaustivo de la Enfermedad de Huntington (EH) en Juan de Acosta, Colombia, abordando cuatro componentes clave: neuropsicológico, genético, neuroanatómico e histórico. El componente histórico abordó el "Efecto Fundador" de la EH en Juan de Acosta, explorando la ascendencia vasca, la migración durante la colonización española y la conexión entre datos genealógicos y la prevalencia de EH. Se resaltó la relevancia de la subestructura interna en la población vasca y la existencia de mutaciones fundacionales. Desde la perspectiva neuropsicológica, se identificaron marcadores tempranos en la EH mediante pruebas específicas, como la copia de la figura del rey y la prueba Stroop. Individuos en fase premotora mostraron alteraciones significativas en habilidades visoconstructivas e inhibición cognitiva, sugiriendo su potencial como marcadores tempranos de disfunción neurocognitiva. En el componente genético, se realizó el análisis genómico de 291 individuos reveló repeticiones CAG en el gen huntingtina (HTT), destacando los alelos 17/7 y 17/10 como los más comunes y evidenciando un aumento de mosaicismo con la edad. La investigación neuroanatómica se centró en alteraciones volumétricas cerebrales en individuos premanifiestos, identificando cambios significativos, como la disminución del volumen del parénquima cerebral en la penetrancia completa y hallazgos sorprendentes en el grupo intermedio. La dilatación ventricular emergió como un indicador potencial de la progresión global de la enfermedad. En conjunto, esta tesis proporciona una visión completa de la EH en Juan de Acosta, integrando aspectos neuropsicológicos, genéticos, neuroanatómicos e históricos. Estos hallazgos no solo enriquecen la comprensión de la enfermedad, sino que también tienen implicaciones cruciales para la detección temprana, intervenciones preventivas y gestión clínica en esta población.spa
dc.description.abstractThis thesis presents a comprehensive analysis of Huntington's Disease (HD) in Juan de Acosta, Colombia, addressing four key components: neuropsychological, genetic, neuroanatomical, and historical. The historical component delved into the "Founder Effect" of HD in Juan de Acosta, exploring Basque ancestry, migration during Spanish colonization, and the connection between genealogical data and HD prevalence. The relevance of internal substructure in the Basque population and the existence of founder mutations were emphasized. From a neuropsychological perspective, early markers in HD were identified through specific tests such as the King's figure copy and the Stroop test. Individuals in the premanifest phase showed significant alterations in visuospatial skills and cognitive inhibition, suggesting their potential as early markers of neurocognitive dysfunction. In the genetic component, genomic analysis of 291 individuals revealed CAG repeats in the huntingtin gene (HTT), highlighting the 17/7 and 17/10 alleles as the most common and showing an increase in mosaicism with age. Neuroanatomical research focused on brain volumetric alterations in premanifest individuals, identifying significant changes such as decreased cerebral parenchymal volume in complete penetrance and surprising findings in the intermediate group. Ventricular dilation emerged as a potential indicator of overall disease progression. Overall, this thesis provides a comprehensive view of HD in Juan de Acosta, integrating neuropsychological, genetic, neuroanatomical, and historical aspects. These findings not only enrich the understanding of the disease but also have crucial implications for early detection, preventive interventions, and clinical management in this population.eng
dc.format.mimetypepdf
dc.identifier.urihttps://hdl.handle.net/20.500.12442/14533
dc.language.isospa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias Básicas y Biomédicasspa
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPremotores EHspa
dc.subjectHabilidades visoconstructivasspa
dc.subjectInhibiciónspa
dc.subjectMarcadores tempranosspa
dc.subjectEnfermedad de Huntingtonspa
dc.subjectHTTspa
dc.subjectRepeticiones CAGspa
dc.subjectMosaicismospa
dc.subjectDeslizamientospa
dc.subjectEH premanifiestaspa
dc.subjectBiomarcadoresspa
dc.subjectCambios volumétricos cerebralesspa
dc.subjectDilatación ventricularspa
dc.subjectEfecto Fundadorspa
dc.subjectAscendencia vascaspa
dc.subjectMigración colonialspa
dc.subjectDatos genealógicosspa
dc.subjectPrevalencia diferencialspa
dc.subjectPremanifest HD dilationeng
dc.subjectVisuospatial skillseng
dc.subjectEarly markerseng
dc.subjectHuntington's diseaseeng
dc.subjectCAG repeatseng
dc.subjectMosaicismeng
dc.subjectSlippageeng
dc.subjectPremanifest HDeng
dc.subjectBiomarkerseng
dc.subjectBrain volumetric changeseng
dc.subjectVentricular dilationeng
dc.subjectFounder Effecteng
dc.subjectBasque ancestryeng
dc.subjectColonial migrationeng
dc.subjectGenealogical dataeng
dc.subjectDifferential prevalenceeng
dc.titleExploración integral de la enfermedad de Huntington en Juan de Acosta, Colombia: perspectivas históricas, neuropsicológicas, genéticas y neuroanatómicasspa
dc.type.driverinfo:eu-repo/semantics/doctoralThesis
dc.type.spaTesis de doctorado
dcterms.referencesA worldwide study of the HD mutation. (1994)eng
dcterms.referencesAbeyasinghe, P. M., Long, J. D., Razi, A., Pustina, D., Paulsen, J. S., Tabrizi, S. J., Poudel, G. R., & Georgiou-Karistianis, N. (2021). Tracking Huntingtonʼs Disease Progression Using Motor, Functional, Cognitive, and Imaging Markers. Movement Disorders, 36(10), 2282–2292. https://doi.org/10.1002/mds.28650eng
dcterms.referencesAgostinho, L. D. A., Rocha, C. F., Medina-Acosta, E., Barboza, H. N., Da Silva, A. F. A., Pereira, S. P. F., Da Silva, I. D. S., Paradela, E. R., Figueiredo, A. L. D. S., Nogueira, E. D. M., Alvarenga, R. M. P., Hernan Cabello, P., Dos Santos, S. R., & Paiva, C. L. A. (2012). Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington’s disease. Journal of Human Genetics, 57(12), 796–803. https://doi.org/10.1038/jhg.2012.120eng
dcterms.referencesAguirre, A., Vicario, A., Mazón, L. I., Estomba, A., Martínez De Pancorbo, M., Arrieta Picó, V., Perez Elortondo, F., & Lostao, C. M. (1991). Are the Basques a single and a unique population? American Journal of Human Genetics, 49(2), 450–458.eng
dcterms.referencesAhmad, M., Ríos-Anillo, M. R., Acosta-López, J. E., Cervantes-Henríquez, M. L., Martínez-Banfi, M., Pineda-Alhucema, W., Puentes-Rozo, P., Sánchez-Barros, C., Pinzón, A., Patel, H. R., Vélez, J. I., Villarreal-Camacho, J. L., Pineda, D. A., ArcosBurgos, M., & Sánchez-Rojas, M. (2023). Uncovering the Genetic and Molecular Features of Huntington’s Disease in Northern Colombia. International Journal of Molecular Sciences, 24(22). https://doi.org/10.3390/ijms242216154eng
dcterms.referencesAl-Eitan, L. N., Rababa’h, D. M., Hakooz, N. M., Alghamdi, M. A., & Dajani, R. B. (2020). Genetic polymorphisms of pharmacogenes among the genetically isolated circassian subpopulation from jordan. Journal of Personalized Medicine, 10(1). https://doi.org/10.3390/jpm10010002eng
dcterms.referencesAlfonso, H. S. (1996). Caracterización de las secuencias polimórficas de tripletes CAG y CCG del gen de la enfermedad de Huntington en familias colombianas. Acta Méd Colomb, 12, 70–75.spa
dcterms.referencesAlonso, S., Flores, C., Cabrera, V., Alonso, A., Martín, P., Albarrán, C., Izagirre, N., de la Rúa, C., & García, O. (2005). The place of the Basques in the European Ychromosome diversity landscape. European Journal of Human Genetics, 13(12), 1293–1302. https://doi.org/10.1038/sj.ejhg.5201482eng
dcterms.referencesAmedi, A., Jacobson, G., Hendler, T., Malach, R., & Zohary, E. (2002). Convergence of visual and tactile shape processing in the human lateral occipital complex. Cerebral Cortex, 12(11), 1202–1212.eng
dcterms.referencesApolinário, T. A., da Silva, I. dos S., Agostinho, L. de A., & Paiva, C. L. A. (2020). Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families. Molecular Genetics and Genomic Medicine, 8(4), 1–8. https://doi.org/10.1002/mgg3.1181eng
dcterms.referencesArango-Lasprilla, J. C., Iglesias-Dorado, J., & Lopera, F. (2003). Características clínicas y neuropsicológicas de la enfermedad de Huntington: Una revisiónrevision. Revista de Neurologia, 37(8), 758–765. https://doi.org/10.33588/rn.3708.2003010spa
dcterms.referencesArcos-Burgos, M., & Muenke, M. (2002). Genetics of population isolates. Clinical Genetics, 61(4), 233–247. https://doi.org/10.1034/j.1399-0004.2002.610401.xeng
dcterms.referencesAstafiev, S. V, Stanley, C. M., Shulman, G. L., & Corbetta, M. (2004). Extrastriate body area in human occipital cortex responds to the performance of motor actions. Nature Neuroscience, 7(5), 542–548.eng
dcterms.referencesAylward, E. H., Anderson, N. B., Bylsma, F. W., Wagster, M. V, Barta, P. E., Sherr, M., Feeney, J., Davis, A., Rosenblatt, A., Pearlson, G. D., & Ross, C. A. (1998). Frontal lobe volume in patients with Huntington’s disease. Neurology, 50(1), 252–258. https://doi.org/10.1212/wnl.50.1.252eng
dcterms.referencesBaeta, M., Nunez, C., Cardoso, S., Palencia-Madrid, L., Pineiro-Hermida, S., ArribaBarredo, M., Villanueva-Millan, M. J., & De Pancorbo, M. M. (2015). Different Evolutionary History for Basque Diaspora Populations in USA and Argentina Unveiled by Mitochondrial DNA Analysis. PLoS ONE, 10(12), 1–13. https://doi.org/10.1371/journal.pone.0144919eng
dcterms.referencesBaizer, J. S., Desimone, R., & Ungerleider, L. G. (1993). Comparison of subcortical connections of inferior temporal and posterior parietal cortex in monkeys. Visual Neuroscience, 10(1), 59–72.eng
dcterms.referencesBamshad, M., & Wooding, S. P. (2003). Signatures of natural selection in the human genome. Nature Reviews Genetics, 4(2), 99–110. https://doi.org/10.1038/nrg999eng
dcterms.referencesBauduer, F. (2008). [History of biological anthropology of the Basque population: empiricism with molecular genetics]. Histoire des sciences medicales, 42(2), 123– 130.eng
dcterms.referencesBauduer, F., Feingold, J., & Lacombe, D. (2005). The Basques: review of population genetics and Mendelian disorders. Human Biology, 77(5), 619–637. https://doi.org/10.1353/hub.2006.0001eng
dcterms.referencesBinder, L. M. (1982). Constructional strategies on complex figure drawings after unilateral brain damage. Journal of Clinical Neuropsychology, 4(1), 51–58. https://doi.org/10.1080/01688638208401116eng
dcterms.referencesBourgain, C., & Génin, E. (2005). Complex trait mapping in isolated populations: Are specific statistical methods required? European Journal of Human Genetics, 13(6), 698–706. https://doi.org/10.1038/sj.ejhg.5201400eng
dcterms.referencesBradley, I. M., Pinto, A. J., & Guest, J. S. (2016). Gene-Specific Primers for Improved Characterization of Mixed Phototrophic Communities. Applied and Environmantal Microbiology, 82(19), 5878–5891. https://doi.org/10.1128/AEM.01630-16.Editoreng
dcterms.referencesBraisch, U., Muche, R., Rothenbacher, D., Landwehrmeyer, G. B., Long, J. D., & Orth, M. (2019). Identification of symbol digit modality test score extremes in Huntington’s disease. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 180(3), 232–245. https://doi.org/10.1002/ajmg.b.32719eng
dcterms.referencesBrand, A., Bradley, M. T., Best, L. A., & Stoica, G. (2008). Accuracy of effect size estimates from published psychological research. Percept Mot Skills, 106(2), 645–649. https://doi.org/10.2466/pms.106.2.645-649eng
dcterms.referencesBrandt, J., Shpritz, B., Munro, C. A., Marsh, L., & Rosenblatt, A. (2005). Differential impairment of spatial location memory in Huntington’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 76(11), 1516–1519. https://doi.org/10.1136/jnnp.2004.059253eng
dcterms.referencesBurgess, N., Maguire, E. A., & O’Keefe, J. (2002). The human hippocampus and spatial and episodic memory. Neuron, 35(4), 625–641.eng
dcterms.referencesBurrell, A. S., & Disotell, T. R. (2009). Panmixia postponed: Ancestry-related assortative mating in contemporary human populations. Genome Biology, 10(11). https://doi.org/10.1186/gb-2009-10-11-245eng
dcterms.referencesBurton, A. (2013). Hope, humanity, and Huntington’s disease in Latin America. The Lancet Neurology, 12(2), 133–134. https://doi.org/10.1016/S1474-4422(13)70006-1eng
dcterms.referencesCalafell, F., & Bertranpetit, J. (1994a). Mountains and genes: population history of the Pyrenees. Human Biology, 66(5), 823–842eng
dcterms.referencesCalafell, F., & Bertranpetit, J. (1994b). Principal component analysis of gene frequencies and the origin of Basques. American Journal of Physical Anthropology, 93(2), 201– 215. https://doi.org/10.1002/ajpa.1330930205eng
dcterms.referencesCarella, F., Bressanelli, M., Piacentini, S., Soliveri, P., Geminiani, G., Monza, D., Albanese, A., & Girotti, F. (2003). A study of arm movements in Huntington’s disease under visually controlled and blindfolded conditions. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 23(6), 287–293. https://doi.org/10.1007/s100720300003eng
dcterms.referencesCarlozzi, N. E., Stout, J. C., Mills, J. A., Duff, K., Beglinger, L. J., Aylward, E. H., Whitlock, K. B., Solomon, A. C., Queller, S., Langbehn, D. R., Johnson, S. A., & Paulsen, J. S. (2011). Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease. The Clinical Neuropsychologist, 25(5), 757–777. https://doi.org/10.1080/13854046.2011.577811eng
dcterms.referencesCasella, C., Lipp, I., Rosser, A., Jones, D. K., & Metzler-Baddeley, C. (2020). A Critical Review of White Matter Changes in Huntington’s Disease. Movement Disorders : Official Journal of the Movement Disorder Society, 35(8), 1302–1311. https://doi.org/10.1002/mds.28109eng
dcterms.referencesCastilla, E. E., & Adams, J. (1996). Genealogical information and the structure of rural Latin-American populations: reality and fantasy. Human Heredity, 46(5), 241–255. https://doi.org/10.1159/000154361eng
dcterms.referencesCastro, M. De, & Restrepo, C. M. (2015). Genetics and genomic medicine in colombia. Molecular Genetics and Genomic Medicine, 3(2), 84–91. https://doi.org/10.1002/mgg3.139eng
dcterms.referencesCeccarini, J., Ahmad, R., Van De Vliet, L., Casteels, C., Vandenbulcke, M., Vandenberghe, W., & Van Laere, K. (2019). Behavioral symptoms in premanifest Huntington disease correlate with reduced frontal CB 1 R levels. Journal of Nuclear Medicine, 60(1), 115–121. https://doi.org/10.2967/jnumed.118.210393eng
dcterms.referencesCiosi, M., Cumming, S., Alshammari, A., Symeonidi, E., Herzyk, P., McGuinness, D., Galbraith, J., Hamilton, G., & Monckton, D. (2020). Library preparation and MiSeq sequencing for the genotyping-by-sequencing of the Huntington disease HTT exon one trinucleotide repeat and the quantification of somatic mosaicism. https://doi.org/10.21203/rs.2.1581/v2eng
dcterms.referencesClever, F., Cho, I. K., Yang, J., & Chan, A. W. S. (2019). Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington’s Disease Monkeys. Journal of Huntington’s Disease, 8(4), 443–448. https://doi.org/10.3233/JHD-190359eng
dcterms.referencesCohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. Hillsdle. Erlbaum. Conner, BE (1988). The Box in the Barn. Columbus: Highlights for ….eng
dcterms.referencesCoppen, E. M., Jacobs, M., van der Zwaan, K. F., Middelkoop, H. A. M., & Roos, R. A. C. (2019). Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease. Archives of Clinical Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 34(8), 1320–1328. https://doi.org/10.1093/arclin/acz002eng
dcterms.referencesCoppen, E. M., van der Grond, J., Hart, E. P., Lakke, E. A. J. F., & Roos, R. A. C. (2018). The visual cortex and visual cognition in Huntington’s disease: An overview of current literature. Behavioural Brain Research, 351, 63–74. https://doi.org/10.1016/j.bbr.2018.05.019eng
dcterms.referencesCuevas-Guarnizo, A. (2014). La enfermedad rara más común en Juan de Acosta. El Espectadoreng
dcterms.referencesDANE. (2019). Resultados Censo Nacional de Población y Vivienda 2018 Sogamoso, Tunja, Boyacá. 27.eng
dcterms.referencesDaza, J., Carbonell, C., & B. A. (1995). Correlación clínico-molecular y caracterización de la enfermedad de Huntington en familias de Juan de Acosta y otras regiones colombianas. 4., 300–321.eng
dcterms.referencesDaza B, Caiaffa RH, Arteta BJV, Echevarría RV, E. M. & A. R. (1991). Estudio neuroepidemiológico enJuandeAcosta,Atlántico,Colombia. ActaMédCoI, 17, 324.eng
dcterms.referencesDaza, B., Caiaffa, R. H., Arteta, B. J., Echeverría, R. V, Ladrón de Guevara, Z., & Escamilla, M. (1992). Estudio neuroepidemiológico en Juan de Acosta, Atlántico, Colombia. Acta Med Colomb, 17, 324.eng
dcterms.referencesDaza J., Carbonell, C., Brokate A., & Caiaffa H. (1996). Caracterización de las secuencias polimórficas de tripletas CAG y CCG del gen de la enfermedad de Huntington en familias colombianas. Acta Neurologica Colombiana, 12., 70–75.eng
dcterms.referencesDe Castro, M., & Restrepo, C. M. (2015). Genetics and genomic medicine in Colombia. Mol Genet Genomic Med, 3(2), 84–91. https://doi.org/10.1002/mgg3.139eng
dcterms.referencesDepartamento Administrativo Nacional de Estadistica (DANE). (2007). Colombia una Nación Multicultural. Colombia Una Nación Multicultural, Su Diversidad Étnica, 1– 45.eng
dcterms.referencesDhalla, A., Pallikadavath, S., & Hutchinson, C. V. (2019). Visual Dysfunction in Huntington’s Disease: A Systematic Review. Journal of Huntington’s Disease, 8(2), 233–242. https://doi.org/10.3233/JHD-180340eng
dcterms.referencesDivac, I., Rosvold, H. E., & Szwarcbart, M. K. (1967). Behavioral effects of selective ablation of the caudate nuceng
dcterms.referencesEddy, C. M., & Rickards, H. E. (2015). Cognitive deficits predict poorer functional capacity in Huntington’s disease: but what is being measured? Neuropsychology, 29(2), 268–273. https://doi.org/10.1037/neu0000134eng
dcterms.referencesEpping, E. A., Kim, J.-I., Craufurd, D., Brashers-Krug, T. M., Anderson, K. E., McCusker, E., Luther, J., Long, J. D., & Paulsen, J. S. (2016). Longitudinal Psychiatric Symptoms in Prodromal Huntington’s Disease: A Decade of Data. The American Journal of Psychiatry, 173(2), 184–192. https://doi.org/10.1176/appi.ajp.2015.14121551eng
dcterms.referencesEtcheverry, M. A. (1945). El factor rhesus su genetica e importancia clinica. El Dia medico, 17, 1237–1251.eng
dcterms.referencesFadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014). An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome, 2(1), 1–7. https://doi.org/10.1186/2049-2618-2-6eng
dcterms.referencesFennema-Notestine, C., Archibald, S. L., Jacobson, M. W., Corey-Bloom, J., Paulsen, J. S., Peavy, G. M., Gamst, A. C., Hamilton, J. M., Salmon, D. P., & Jernigan, T. L. (2004). In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology, 63(6), 989–995. https://doi.org/10.1212/01.wnl.0000138434.68093.67eng
dcterms.referencesFielding, J., Georgiou-Karistianis, N., Millist, L., & White, O. (2006). Temporal variation in the control of goal-directed visuospatial attention in basal ganglia disorders. Neuroscience Research, 54(1), 57–65.eng
dcterms.referencesFinke, K., Bublak, P., Dose, M., Müller, H. J., & Schneider, W. X. (2006). Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington’s disease. Brain : A Journal of Neurology, 129(Pt 5), 1137–1151. https://doi.org/10.1093/brain/awl040eng
dcterms.referencesFranco-Giraldo, Á. (2012). La última reforma del sistema general de seguridad social en salud colombiano. Revista de Salud Pública, 14, 865–877.eng
dcterms.referencesFUNPEHUJAC. (2004). Fundacion por Pacientes con la Enfermedad de Huntington en Juan de Acosta. Unpublishe, [Proposal for the first conference for Colombian’s.eng
dcterms.referencesGarcia-Gorro, C., Llera, A., Martinez-Horta, S., Perez-Perez, J., Kulisevsky, J., RodriguezDechicha, N., Vaquer, I., Subira, S., Calopa, M., Muñoz, E., Santacruz, P., RuizIdiago, J., Mareca, C., Beckmann, C. F., de Diego-Balaguer, R., & Camara, E. (2019). Specific patterns of brain alterations underlie distinct clinical profiles in Huntington’s disease. NeuroImage. Clinical, 23, 101900. https://doi.org/10.1016/j.nicl.2019.101900eng
dcterms.referencesGauvin, H., Lefebvre, J. F., Moreau, C., Lavoie, E. M., Labuda, D., Vézina, H., & RoyGagnon, M. H. (2015). GENLIB: An R package for the analysis of genealogical data. BMC Bioinformatics, 16(1), 1–10. https://doi.org/10.1186/s12859-015-0581-5eng
dcterms.referencesGerovska, D., Irizar, H., Otaegi, D., Ferrer, I., López de Munain, A., & Araúzo-Bravo, M. J. (2020). Genealogy of the neurodegenerative diseases based on a meta-analysis of age-stratified incidence data. Scientific Reports, 10(1), 18923. https://doi.org/10.1038/s41598-020-75014-8eng
dcterms.referencesGlangetas, C., Espinosa, P., & Bellone, C. (2020). Deficit in Motor Skill ConsolidationDependent Synaptic Plasticity at Motor Cortex to Dorsolateral Striatum Synapses in a Mouse Model of Huntington’s Disease. ENeuro, 7(2). https://doi.org/10.1523/ENEURO.0297-19.2020eng
dcterms.referencesGómez-Ansón, B., Alegret, M., Muñoz, E., Monté, G. C., Alayrach, E., Sánchez, A., Boada, M., & Tolosa, E. (2009). Prefrontal cortex volume reduction on MRI in preclinical Huntington’s disease relates to visuomotor performance and CAG number. Parkinsonism & Related Disorders, 15(3), 213–219. https://doi.org/10.1016/j.parkreldis.2008.05.010eng
dcterms.referencesGómez-Tortosa, E., del Barrio, A., Barroso, T., & García Ruiz, P. J. (1996). Visual processing disorders in patients with Huntington’s disease and asymptomatic carriers. Journal of Neurology, 243(3), 286–292. https://doi.org/10.1007/BF00868528eng
dcterms.referencesGorrochategui, J. (2002). Plant eamient os de la lingüíst ica hist órica en la dat ación del Euskara.eng
dcterms.referencesGregory, S., Scahill, R. I., Rees, G., & Tabrizi, S. (2018a). Magnetic resonance imaging in Huntington’s disease. Methods in Molecular Biology, 1780, 303–328. https://doi.org/10.1007/978-1-4939-7825-0_16eng
dcterms.referencesGregory, S., Scahill, R. I., Rees, G., & Tabrizi, S. (2018b). Magnetic Resonance Imaging in Huntington’s Disease BT - Huntington’s Disease (S. V Precious, A. E. Rosser, & S. B. Dunnett (Eds.); pp. 303–328). Springer New York. https://doi.org/10.1007/978-1- 4939-7825-0_16eng
dcterms.referencesGusella, J. F., & MacDonald, M. E. (2006). Huntington’s disease: seeing the pathogenic process through a genetic lens. Trends in Biochemical Sciences, 31(9), 533–540. https://doi.org/10.1016/j.tibs.2006.06.009eng
dcterms.referencesGusella, J. F., & MacDonald, M. E. (2009). Huntington’s disease: the case for genetic modifiers. Genome Medicine, 1(8), 80. https://doi.org/10.1186/gm80eng
dcterms.referencesHa, A. D., & Fung, V. S. C. (2012). Huntington’s disease. Current Opinion in Neurology, 25(4), 491–498. https://doi.org/10.1097/WCO.0b013e3283550c97eng
dcterms.referencesHarris, K. L., Armstrong, M., Swain, R., Erzinclioglu, S., Das, T., Burgess, N., Barker, R. A., & Mason, S. L. (2019). Huntington’s disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 119, 417–427. https://doi.org/10.1016/j.cortex.2019.07.014eng
dcterms.referencesHayden Berkowicz, AL, Beighton, PH & Yiptong, C, M. R. (1981). Huntington’s chorea on the island of Mauritius. South African Medical Journal, 60(26), 1001–1002.eng
dcterms.referencesHeindel, W. C., Butters, N., & Salmon, D. P. (1988). Impaired learning of a motor skill in patients with Huntington’s disease. Behavioral Neuroscience, 102(1), 141–147. https://doi.org/10.1037//0735-7044.102.1.141eng
dcterms.referencesHeutink, P., & Oostra, B. A. (2002). Gene finding in genetically isolated populations. Human Molecular Genetics, 11(20), 2507–2515. https://doi.org/10.1093/hmg/11.20.2507eng
dcterms.referencesHobbs, N. Z., Barnes, J., Frost, C., Henley, S. M. D., Wild, E. J., Macdonald, K., Barker, R. A., Scahill, R. I., Fox, N. C., & Tabrizi, S. J. (2010). Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. AJNR. American Journal of Neuroradiology, 31(6), 1036–1041. https://doi.org/10.3174/ajnr.A2018eng
dcterms.referencesIhaka, R., & Gentleman, R. (1996). R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics, 5(3), 299–314. https://doi.org/10.2307/1390807.eng
dcterms.referencesIriondo, M., Barbero, M. C., & Manzano, C. (2003). DNA polymorphisms detect ancient barriers to gene flow in Basques. American Journal of Physical Anthropology, 122(1), 73–84. https://doi.org/10.1002/ajpa.10212eng
dcterms.referencesJensen, R. N., Bolwig, T., & Sørensen, S. A. (2018). [Psychiatric symptoms in patients with Huntington’s disease]. Ugeskrift for laeger, 180(13).eng
dcterms.referencesJohnson, E. B., Rees, E. M., Labuschagne, I., Durr, A., Leavitt, B. R., Roos, R. A. C., Reilmann, R., Johnson, H., Hobbs, N. Z., Langbehn, D. R., Stout, J. C., Tabrizi, S. J., & Scahill, R. I. (2015). The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington’s Disease. Neuropsychologia, 79(Pt A), 138–146. https://doi.org/10.1016/j.neuropsychologia.2015.10.033eng
dcterms.referencesJorde, L. B., Watkins, W. S., Kere, J., Nyman, D., & Eriksson, A. W. (2000). Gene mapping in isolated populations: new roles for old friends? Human Heredity, 50(1), 57–65. https://doi.org/10.1159/000022891eng
dcterms.referencesJorde, L. B., & Wooding, S. P. (2004). Genetic variation, classification and {\textquoteleft}race{\textquoteright}. Nature Genetics, 36(11), 1–6. https://doi.org/10.1034/ng1435eng
dcterms.referencesKandt, J., & Longley, P. A. (2018). Ethnicity estimation using family naming practices. PLOS ONE, 13(8), e0201774.eng
dcterms.referencesKay, C., Hayden, M. R., & Leavitt, B. R. (2017). Epidemiology of Huntington disease. Handbook of Clinical Neurology, 144, 31–46. https://doi.org/10.1016/B978-0-12- 801893-4.00003-1eng
dcterms.referencesKhan, W., Alusi, S., Tawfik, H., & Hussain, A. (2021). The relationship between nonmotor features and weight-loss in the premanifest stage of Huntington’s disease. PLOS ONE, 16(7), 1–24. https://doi.org/10.1371/journal.pone.0253817eng
dcterms.referencesKim, A., Lalonde, K., Truesdell, A., Gomes Welter, P., Brocardo, P. S., Rosenstock, T. R., & Gil-Mohapel, J. (2021). New Avenues for the Treatment of Huntington’s Disease. International Journal of Molecular Sciences, 22(16). https://doi.org/10.3390/ijms22168363eng
dcterms.referencesKremer, H. P. H., & Group, H. S. (1996). Unified Huntington’s disease rating scale: reliability and consistency. Movement Disorders, 11, 136–142.eng
dcterms.referencesKristiansson, K., Naukkarinen, J., & Peltonen, L. (2008). Isolated populations and complex disease gene identification. Genome Biology, 9(8), 1–9. https://doi.org/10.1186/gb2008-9-8-109eng
dcterms.referencesLaayouni, H., Calafell, F., & Bertranpetit, J. (2010). A genome-wide survey does not show the genetic distinctiveness of Basques. Human Genetics, 127(4), 455–458. https://doi.org/10.1007/s00439-010-0798-3eng
dcterms.referencesLangbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & Group, an I. H. D. C. (2004). A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clinical Genetics, 65(4), 267–277.eng
dcterms.referencesLangbehn, D. R., Stout, J. C., Gregory, S., Mills, J. A., Durr, A., Leavitt, B. R., Roos, R. A. C., Long, J. D., Owen, G., Johnson, H. J., Borowsky, B., Craufurd, D., Reilmann, R., Landwehrmeyer, G. B., Scahill, R. I., & Tabrizi, S. J. (2019). Association of CAG Repeats With Long-term Progression in Huntington Disease. JAMA Neurology, 76(11), 1375–1385. https://doi.org/10.1001/jamaneurol.2019.2368eng
dcterms.referencesLarmuseau, M. H. D., Ottoni, C., Raeymaekers, J. A. M., Vanderheyden, N., Larmuseau, H. F. M., & Decorte, R. (2012). Temporal differentiation across a West-European Ychromosomal cline: Genealogy as a tool in human population genetics. European Journal of Human Genetics, 20(4), 434–440. https://doi.org/10.1038/ejhg.2011.218eng
dcterms.referencesLarsson, J., & Heeger, D. J. (2006). Two retinotopic visual areas in human lateral occipital cortex. Journal of Neuroscience, 26(51), 13128–13142. https://doi.org/10.1523/JNEUROSCI.1657-06.2006eng
dcterms.referencesLawrence, A. D., Watkins, L. H. A., Sahakian, B. J., Hodges, J. R., & Robbins, T. W. (2000). Visual object and visuospatial cognition in Huntington’s disease: implications for information processing in corticostriatal circuits. Brain, 123(7), 1349–1364. https://doi.org/10.1093/brain/123.7.1349eng
dcterms.referencesLee, S.-Y., Yoon, S.-Y., Kim, M.-J., Rhee, H., Ryu, C., & Jahng, G.-H. (2013). Investigation of the Correlation between Seoul Neuropsychological Screening Battery Scores and the Gray Matter Volume after Correction of Covariates of the Age, Gender, and Genotypes in Patients with AD and MCI. Journal of the Korean Society of Magnetic Resonance in Medicine, 17, 294. https://doi.org/10.13104/jksmrm.2013.17.4.294eng
dcterms.referencesLemay, M., Fimbel, E., Beuter, A., Chouinard, S., & Richer, F. (2005). Sensorimotor mapping affects movement correction deficits in early Huntington’s disease. Experimental Brain Research, 165(4), 454–460. https://doi.org/10.1007/s00221-005- 2315-9eng
dcterms.referencesLiascovich, R., Rittler, M., & Castilla, E. E. (2001). Consanguinity in South America: demographic aspects. Human Heredity, 51(1–2), 27–34. https://doi.org/10.1159/000022956eng
dcterms.referencesLinares Gómez Andrea. (2009). Por causa de gen maligno, un pueblo debe evitar reproducirse. ESPECIAL DE EL TIEMPO.spa
dcterms.referencesLiu, H., Zhang, C., Xu, J., Jin, J., Cheng, L., Miao, X., Wu, Q., Wei, Z., Liu, P., Lu, H., van Zijl, P. C. M., Ross, C. A., Hua, J., & Duan, W. (2021). Huntingtin silencing delays onset and slows progression of Huntington’s disease: a biomarker study. Brain : A Journal of Neurology, 144(10), 3101–3113. https://doi.org/10.1093/brain/awab190eng
dcterms.referencesLo, J., Reyes, A., Pulverenti, T. S., Rankin, T. J., Bartlett, D. M., Zaenker, P., Rowe, G., Feindel, K., Poudel, G., Georgiou-Karistianis, N., Ziman, M. R., & Cruickshank, T. M. (2020). Dual tasking impairments are associated with striatal pathology in Huntington’s disease. Annals of Clinical and Translational Neurology, 7(9), 1608– 1619. https://doi.org/10.1002/acn3.51142eng
dcterms.referencesMacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S. A., James, M., Groot, N., MacFarlane, H., Jenkins, B., Anderson, M. A., Wexler, N. S., Gusella, J. F., Bates, G. P., Baxendale, S., Hummerich, H., Kirby, S., … Harper, P. S. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983. https://doi.org/10.1016/0092-8674(93)90585-Eeng
dcterms.referencesMaestre, R., Bermúdez, A., Ching, R., Mejía, G., Malambo, D., & Gómez, D. (2010). Diagnóstico molecular de la Enfermedad de Huntington en el departamento del Atlántico , Colombia (2009). Iatreia, 23(4-S SE-Resúmenes).eng
dcterms.referencesMarchina, E., Misasi, S., Bozzato, A., Ferraboli, S., Agosti, C., Rozzini, L., Borsani, G., Barlati, S., & Padovani, A. (2014). Gene expression profile in fibroblasts of Huntington’s disease patients and controls. Journal of the Neurological Sciences, 337(1–2), 42–46. https://doi.org/10.1016/j.jns.2013.11.014eng
dcterms.referencesMartínez-Horta, S., Horta-Barba, A., Perez-Perez, J., Antoran, M., Pagonabarraga, J., Sampedro, F., & Kulisevsky, J. (2020). Impaired face-like object recognition in premanifest Huntington’s disease. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 123, 162–172. https://doi.org/10.1016/j.cortex.2019.10.015eng
dcterms.referencesMartinez-Horta, S., Sampedro, F., Horta-Barba, A., Perez-Perez, J., Pagonabarraga, J., Gomez-Anson, B., & Kulisevsky, J. (2020). Structural brain correlates of dementia in Huntington’s disease. NeuroImage. Clinical, 28, 102415. https://doi.org/10.1016/j.nicl.2020.102415eng
dcterms.referencesMasuda, N., Goto, J., Murayama, N., Watanabe, M., Kondo, I., & Kanazawa, I. (1995). Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington’s disease. Journal of Medical Genetics, 32(9), 701–705. https://doi.org/10.1136/jmg.32.9.701eng
dcterms.referencesMaxwell, A. (2022). ScaleHD Documentation.eng
dcterms.referencesMcColgan, P., Gregory, S., Seunarine, K. K., Razi, A., Papoutsi, M., Johnson, E., Durr, A., Roos, R. A. C., Leavitt, B. R., Holmans, P., Scahill, R. I., Clark, C. A., Rees, G., & Tabrizi, S. J. (2018). Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes. Biological Psychiatry, 83(5), 456–465. https://doi.org/10.1016/j.biopsych.2017.10.019eng
dcterms.referencesMishkin, M., Lewis, M. E., & Ungerleider, L. G. (1982). Equivalence of parietopreoccipital subareas for visuospatial ability in monkeys. Behavioural Brain Research, 6(1), 41–55.eng
dcterms.referencesMishkin, M., & Ungerleider, L. G. (1982). Contribution of striate inputs to the visuospatial functions of parieto-preoccipital cortex in monkeys. Behavioural Brain Research, 6(1), 57–77eng
dcterms.referencesMisnaza Castrillon, S. P., & Armenta-Restrepo, A. (2017). Indice modificado de esfuerzo en cuidadores informales de personas con Enfermedad de Huntington en los Municipios de Algarrobo, Ariguani y San Angel. Magdalena, Colombia. Rev. Med. Risaralda, 3–7.spa
dcterms.referencesMohr, E., Brouwers, P., Claus, J. J., Mann, U., Fedio, P., & Chase, T. (1991). Visuospatial cognition in Huntington’s disease. Movement Disorders, 6.eng
dcterms.referencesMoses, J. A., Golden, C. J., Berger, P. A., & Wisniewski, A. M. (1981). Neuropsychological Deficits in Early, Middle, and Late Stage Huntington’s Disease as Measured by the Luria-Nebraska Neuropsychological Battery. International Journal of Neuroscience, 14(1–2), 95–100. https://doi.org/10.3109/00207458108985820eng
dcterms.referencesMyers, R. H. (2004). Huntington’s disease genetics. NeuroRx : The Journal of the American Society for Experimental NeuroTherapeutics, 1(2), 255–262. https://doi.org/10.1602/neurorx.1.2.255eng
dcterms.referencesMyers, R. H., Vonsattel, J. P., Stevens, T. J., Cupples, L. A., Richardson, E. P., Martin, J. B., & Bird, E. D. (1988). Clinical and neuropathologic assessment of severity in Huntington’s disease. Neurology, 38(3), 341.eng
dcterms.referencesNanetti, L., Contarino, V. E., Castaldo, A., Sarro, L., Bachoud-Levi, A.-C., Giavazzi, M., Frittoli, S., Ciammola, A., Rizzo, E., Gellera, C., Bruzzone, M. G., Taroni, F., Grisoli, M., & Mariotti, C. (2018). Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease. Parkinsonism & Related Disorders, 51, 17–23. https://doi.org/10.1016/j.parkreldis.2018.02.033eng
dcterms.referencesNewman, D. L., Abney, M., McPeek, M. S., Ober, C., & Cox, N. J. (2001). The Importance of Genealogy in Determining Genetic Associations with Complex Traits. The American Journal of Human Genetics, 69(5), 1146–1148. https://doi.org/10.1086/323659eng
dcterms.referencesNopoulos, P. C., Aylward, E. H., Ross, C. A., Johnson, H. J., Magnotta, V. A., Juhl, A. R., Pierson, R. K., Mills, J., Langbehn, D. R., & Paulsen, J. S. (2010). Cerebral cortex structure in prodromal Huntington disease. Neurobiology of Disease, 40(3), 544–554. https://doi.org/10.1016/j.nbd.2010.07.014eng
dcterms.referencesO’Brien, E., Jorde, L. B., Rönnlöf, B., Fellman, J. O., & Eriksson, A. W. (1988). Inbreeding and genetic disease in Sottunga, Finland. American Journal of Physical Anthropology, 75(4), 477–486. https://doi.org/10.1002/ajpa.1330750405eng
dcterms.referencesO’Rourke, J. J. F., Adams, W. H., Duff, K., Byars, J., Nopoulos, P., Paulsen, J. S., & Beglinger, L. J. (2011). Estimating premorbid functioning in huntington’s disease: the relationship between disease progression and the wide range achievement test reading subtest. Archives of Clinical Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 26(1), 59–66. https://doi.org/10.1093/arclin/acq088eng
dcterms.referencesOECD. (2017). Digital technology: Making better use of health data.eng
dcterms.referencesOlson, S., Berg, K., Bonham, V., Boyer, J., Brody, L., Brooks, L., Collins, F., Guttmacher, A., McEwen, J., Muenke, M., Olson, S., Wang, V. O., Rodriguez, L. L., Vydelingum, N., & Warshauer-Baker, E. (2005). The use of racial, ethnic, and ancestral categories in human genetics research. American Journal of Human Genetics, 77(4), 519–532. https://doi.org/10.1086/491747eng
dcterms.referencesOrtega-Leonard, L., Orozco-Calderón, G., Vélez, A., & Cruz, F. (2015). The role of the corpus callosum in the visuospatial processing. Rev. Chil. Neuropsicol, 10(1), 25–30. https://doi.org/10.5839/rcnp.2015.10.01.06eng
dcterms.referencesOsterrieth, P. A. (1944). Le test de copie d’une figure complexe; contribution a l’etude de la perception et de la memoire. Archives de Psychologie.eng
dcterms.referencesPaisán-Ruíz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., López de Munain, A., Aparicio, S., Gil, A. M., Khan, N., Johnson, J., Martinez, J. R., Nicholl, D., Martí Carrera, I., Pena, A. S., de Silva, R., Lees, A., Martí-Massó, J. F., Pérez-Tur, J., … Singleton, A. B. (2004). Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron, 44(4), 595–600. https://doi.org/10.1016/j.neuron.2004.10.023eng
dcterms.referencesPalareti, G., Legnani, C., Cosmi, B., Antonucci, E., Erba, N., Poli, D., Testa, S., & Tosetto, A. (2016). Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study. International Journal of Laboratory Hematology, 38(1), 42–49. https://doi.org/10.1111/ijlh.12426eng
dcterms.referencesPaulsen, J. S. (2011). Cognitive impairment in Huntington disease: diagnosis and treatment. Current Neurology and Neuroscience Reports, 11(5), 474–483. https://doi.org/10.1007/s11910-011-0215-xeng
dcterms.referencesPaulsen, J. S., Lourens, S., Kieburtz, K., & Zhang, Y. (2019). Sample enrichment for clinical trials to show delay of onset in huntington disease. Movement Disorders : Official Journal of the Movement Disorder Society, 34(2), 274–280. https://doi.org/10.1002/mds.27595eng
dcterms.referencesPeña-Casanova, J., Gramunt-Fombuena, N., Quiñones-Úbeda, S., Sánchez-Benavides, G., Aguilar, M., Badenes, D., Molinuevo, J. L., Robles, A., Barquero, M. S., Payno, M., Antúnez, C., Martínez-Parra, C., Frank-García, A., Fernández, M., Alfonso, V., Sol, J. M., & Blesa, R. (2009). Spanish multicenter normative studies (NEURONORMA project): Norms for the rey-osterrieth complex figure (copy and memory), and free and cued selective reminding test. Archives of Clinical Neuropsychology, 24(4), 371–393. https://doi.org/10.1093/arclin/acp041eng
dcterms.referencesPeng, C., Zhu, G., Liu, X., & Li, H. (2018). Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C. Neuroscience Bulletin, 34(5), 747– 758. https://doi.org/10.1007/s12264-018-0230-xeng
dcterms.referencesPenney, J. B. J., Vonsattel, J. P., MacDonald, M. E., Gusella, J. F., & Myers, R. H. (1997). CAG repeat number governs the development rate of pathology in Huntington’s disease. Annals of Neurology, 41(5), 689–692. https://doi.org/10.1002/ana.410410521eng
dcterms.referencesPhillips, W., Shannon, K. M., & Barker, R. A. (2008). The current clinical management of Huntington’s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 23(11), 1491–1504. https://doi.org/10.1002/mds.21971eng
dcterms.referencesPierzynowska, K., Gaffke, L., Cyske, Z., & Węgrzyn, G. (2019). Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients. Metabolic Brain Disease, 34(3), 715–720. https://doi.org/10.1007/s11011-019-00405- 4eng
dcterms.referencesPillon, B. (1981). [Visuo-constructive problems and methods of compensation. Results for 85 patients with brain lesions]. Neuropsychologia, 19(3), 375–383. https://doi.org/10.1016/0028-3932(81)90067-1eng
dcterms.referencesPirogovsky, E., Nicoll, D. R., Challener, D. M., Breen, E., Gluhm, S., Corey‐Bloom, J., & Gilbert, P. E. (2015). The Visual Spatial Learning Test: Differential impairment during the premanifest and manifest stages of Huntington’s disease. Journal of Neuropsychology, 9(1), 77–86.eng
dcterms.referencesPodvin, S., Reardon, H. T., Yin, K., Mosier, C., & Hook, V. (2019). Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration. Journal of Neurology, 266(3), 551–564. https://doi.org/10.1007/s00415-018-8940-6eng
dcterms.referencesPotter, N. T., Spector, E. B., & Prior, T. W. (2004). Technical Standards and Guidelines for Huntington Disease Testing. Genetics in Medicine, 6(1), 61–65. https://doi.org/10.1097/01.GIM.0000106165.74751.15eng
dcterms.referencesPringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and metaanalysis. Movement Disorders, 27(9), 1083–1091. https://doi.org/10.1002/mds.25075eng
dcterms.referencesPulkes, T., Papsing, C., Wattanapokayakit, S., & Mahasirimongkol, S. (2014). Cagexpansion haplotype analysis in a population with a low prevalence of huntington’s disease. Journal of Clinical Neurology (Korea), 10(1), 32–36. https://doi.org/10.3988/jcn.2014.10.1.32eng
dcterms.referencesPurcell, N. L., Goldman, J. G., Ouyang, B., Bernard, B., & O’Keefe, J. A. (2019). The Effects of Dual-Task Cognitive Interference and Environmental Challenges on Balance in Huntington’s Disease. Movement Disorders Clinical Practice, 6(3), 202– 212. https://doi.org/10.1002/mdc3.12720eng
dcterms.referencesRawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J. W., & Smeeth, L. (2016). The Prevalence of Huntington’s Disease. Neuroepidemiology, 46(2), 144–153. https://doi.org/10.1159/000443738eng
dcterms.referencesRedondo-Vergé, L. (2001). [Cognitive deterioration in Huntington disease]. Revista de neurologia, 32(1), 82–85.eng
dcterms.referencesRey, A. (1941). L’examen psychologique dans les cas d’encéphalopathie traumatique.(Les problems.). Archives de Psychologie.eng
dcterms.referencesRey, A. (2009). REY. Test de copia de una figura compleja. TEA Ediciones, Madrid.spa
dcterms.referencesRisch, N., Choudhry, S., Via, M., Basu, A., Sebro, R., Eng, C., Beckman, K., Thyne, S., Chapela, R., Rodriguez-Santana, J. R., Rodriguez-Cintron, W., Avila, P. C., Ziv, E., & Gonzalez Burchard, E. (2009). Ancestry-related assortative mating in Latino populations. Genome Biology, 10(11). https://doi.org/10.1186/gb-2009-10-11-r132eng
dcterms.referencesRivera, D., Perrin, P. B., Morlett-Paredes, A., Galarza-Del-Angel, J., Martínez, C., Garza, M. T., Saracho, C. P., Rodríguez, W., Rodríguez-Agudelo, Y., Rábago, B., Aliaga, A., Schebela, S., Luna, M., Longoni, M., Ocampo-Barba, N., Fernández, E., Esenarro, L., García-Egan, P., & Arango-Lasprilla, J. C. (2015). Rey-Osterrieth Complex Figurecopy and immediate recall: Normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation, 37(4), 677–698. https://doi.org/10.3233/NRE151285eng
dcterms.referencesRudan, I., Rudan, D., Campbell, H., Carothers, A., Wright, A., Smolej-Narancic, N., Janicijevic, B., Jin, L., Chakraborty, R., Deka, R., & Rudan, P. (2003). Inbreeding and risk of late onset complex disease. Journal of Medical Genetics, 40(12), 925–932. https://doi.org/10.1136/jmg.40.12.925eng
dcterms.referencesRuiz de Sabando, A., Urrutia Lafuente, E., Galbete, A., Ciosi, M., García Amigot, F., García Solaesa, V., Martínez, V. Á., Martinez-Descals, A., Mila, M., Trujillo-Tiebas, M. J., López-Sendón, J. L., Fenollar-Cortés, M., Legarda, I., Noguera, S. B., Millán, J. M., Durán-Herrera, C., Monckton, D. G., & Ramos-Arroyo, M. A. (2022). Spanish HTT gene study reveals haplotype and allelic diversity with possible implications for germline expansion dynamics in Huntington disease . Human Molecular Genetics, 00(September), 1–10. https://doi.org/10.1093/hmg/ddac224eng
dcterms.referencesRuocco, H. H., Lopes-Cendes, I., Li, L. M., Santos-Silva, M., & Cendes, F. (2006). Striatal and extrastriatal atrophy in Huntington’s disease and its relationship with length of the CAG repeat. Brazilian Journal of Medical and Biological Research = Revista Brasileira de Pesquisas Medicas e Biologicas, 39(8), 1129–1136. https://doi.org/10.1590/s0100-879x2006000800016eng
dcterms.referencesSaloum de Neves Manta, F., Pereira, R., Vianna, R., Rodolfo Beuttenmüller de Araújo, A., Leite Góes Gitaí, D., Aparecida da Silva, D., de Vargas Wolfgramm, E., da Mota Pontes, I., Ivan Aguiar, J., Ozório Moraes, M., Fagundes de Carvalho, E., & Gusmão, L. (2013). Revisiting the Genetic Ancestry of Brazilians Using Autosomal AIMIndels. PLoS ONE, 8(9), 1–11. https://doi.org/10.1371/journal.pone.0075145eng
dcterms.referencesSalzano, F. M., & Sans, M. (2014). Interethnic admixture and the evolution of Latin American populations. Genetics and Molecular Biology, 37(1 SUPPL. 1), 151–170. https://doi.org/10.1590/S1415-47572014000200003eng
dcterms.referencesSánchez-Castañeda, C., Squitieri, F., Di Paola, M., Dayan, M., Petrollini, M., & Sabatini, U. (2015). The role of iron in gray matter degeneration in huntington’s disease: A magnetic resonance imaging study. Human Brain Mapping, 36(1), 50–66. https://doi.org/10.1002/hbm.22612eng
dcterms.referencesSans, M., Figueiro, G., Ackermann, E., Barreto, I., Egaña, A., Bertoni, B., PoittevinGilmet, E., Maytia, D., & Hidalgo, P. C. (2011). Mitochondrial DNA in Basque descendants from the city of Trinidad, Uruguay: Uruguayan- or Basque-like population? Human Biology, 83(1), 55–70. https://doi.org/10.3378/027.083.0104eng
dcterms.referencesSay, M. J., Jones, R., Scahill, R. I., Dumas, E. M., Coleman, A., Santos, R. C. D., Justo, D., Campbell, J. C., Queller, S., Shores, E. A., Tabrizi, S. J., & Stout, J. C. (2011a). Visuomotor integration deficits precede clinical onset in Huntington’s disease. Neuropsychologia, 49(2), 264–270. https://doi.org/10.1016/j.neuropsychologia.2010.11.016eng
dcterms.referencesSay, M. J., Jones, R., Scahill, R. I., Dumas, E. M., Coleman, A., Santos, R. C. D., Justo, D., Campbell, J. C., Queller, S., Shores, E. A., Tabrizi, S. J., & Stout, J. C. (2011b). Visuomotor integration deficits precede clinical onset in Huntington’s disease. Neuropsychologia, 49(2), 264–270. https://doi.org/10.1016/j.neuropsychologia.2010.11.016eng
dcterms.referencesSemaka, A., Kay, C., Doty, C. N., Collins, J. A., Tam, N., & Hayden, M. R. (2013). High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia’s general population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of the International Society of Psychiatric Genetics, 162B(8), 864–871. https://doi.org/10.1002/ajmg.b.32193eng
dcterms.referencesShekari Khaniani, M., Aob, P., Ranjouri, M., & Mansoori Derakhsan, S. (2017). Molecular analysis and prevalence of Huntington disease in northwestern Iran. Turkish Journal of Medical Sciences, 47(6), 1880–1884. https://doi.org/10.3906/sag-1510-25eng
dcterms.referencesShoulson, I., & Fahn, S. (1979). Huntington disease: clinical care and evaluation. Neurology, 29(1), 1.eng
dcterms.referencesSiesling, S., van Vugt, J. P., Zwinderman, K. A., Kieburtz, K., & Roos, R. A. (1998). Unified Huntington’s disease rating scale: a follow up. Movement Disorders : Official Journal of the Movement Disorder Society, 13(6), 915–919. https://doi.org/10.1002/mds.870130609eng
dcterms.referencesSimón-Sánchez, J., Martí-Massó, J.-F., Sánchez-Mut, J. V., Paisán-Ruiz, C., Martínez-Gil, A., Ruiz-Martínez, J., Sáenz, A., Singleton, A. B., López de Munain, A., & Pérez-Tur, J. (2006). Parkinson’s disease due to the R1441G mutation in Dardarin: a founder effect in the Basques. Movement Disorders : Official Journal of the Movement Disorder Society, 21(11), 1954–1959. https://doi.org/10.1002/mds.21114eng
dcterms.referencesSlutsky, D. A., & Recanzone, G. H. (2001). Temporal and spatial dependency of the ventriloquism effect. Neuroreport, 12(1), 7–10. https://doi.org/10.1097/00001756- 200101220-00009eng
dcterms.referencesSnowden, J. S. (2017). The Neuropsychology of Huntington’s Disease. Archives of Clinical Neuropsychology, 32(7), 876–887. https://doi.org/10.1093/arclin/acx086eng
dcterms.referencesSprengelmeyer, R., Young, A. W., Calder, A. J., Karnat, A., Lange, H., Hömberg, V., Perrett, D. I., & Rowland, D. (1996). Loss of disgust: Perception of faces and emotions in Huntington’s disease. Brain, 119(5), 1647–1665. https://doi.org/10.1093/brain/119.5.1647eng
dcterms.referencesSquitieri, F., Cannella, M., Simonelli, M., Sassone, J., Martino, T., Venditti, E., Ciammola, A., Colonnese, C., Frati, L., & Ciarmiello, A. (2009). Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington’s disease. CNS Neuroscience & Therapeutics, 15(1), 1–11. https://doi.org/10.1111/j.1755- 5949.2008.00068.xeng
dcterms.referencesStephens, M., Smith, N. J., & Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics, 68(4), 978–989. https://doi.org/10.1086/319501eng
dcterms.referencesStoker, T. B., Mason, S. L., Greenland, J. C., Holden, S. T., Santini, H., & Barker, R. A. (2022). Huntington’s disease: diagnosis and management. In Practical neurology (Vol. 22, Issue 1, pp. 32–41). NLM (Medline). https://doi.org/10.1136/practneurol2021-003074eng
dcterms.referencesStout, J. C., Paulsen, J. S., Queller, S., Solomon, A. C., Whitlock, K. B., Campbell, J. C., Carlozzi, N., Duff, K., Beglinger, L. J., Langbehn, D. R., Johnson, S. A., Biglan, K. M., & Aylward, E. H. (2011). Neurocognitive signs in prodromal Huntington disease. Neuropsychology, 25(1), 1–14. https://doi.org/10.1037/a0020937eng
dcterms.referencesSvetozarskiy, S. N., Kopishinskaya, S. V, Gustov, A. V, Radyuk, M. A., Antonova, V. A., Smetankin, I. G., Svetozarskiy, S. N., Kopishinskaya, S. V, Gustov, A. V, Radyuk, M. A., Antonova, V. A., & Smetankin, I. G. (2015). [Ophthalmic manifestations of Huntington’s disease]. Vestnik oftalmologii, 131(5), 82–86. https://doi.org/10.17116/oftalma2015131582-86eng
dcterms.referencesTabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., Borowsky, B., Tobin, A. J., Rosas, H. D., Johnson, H., Reilmann, R., Landwehrmeyer, B., & Stout, J. C. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet. Neurology, 8(9), 791–801. https://doi.org/10.1016/S1474-4422(09)70170-Xeng
dcterms.referencesTabrizi, S. J., Leavitt, B. R., Landwehrmeyer, G. B., Wild, E. J., Saft, C., Barker, R. A., Blair, N. F., Craufurd, D., Priller, J., Rickards, H., Rosser, A., Kordasiewicz, H. B., Czech, C., Swayze, E. E., Norris, D. A., Baumann, T., Gerlach, I., Schobel, S. A., Paz, E., … Lane, R. M. (2019). Targeting Huntingtin Expression in Patients with Huntington’s Disease. The New England Journal of Medicine, 380(24), 2307–2316. https://doi.org/10.1056/NEJMoa1900907eng
dcterms.referencesTan, B., Shishegar, R., Fornito, A., Poudel, G., & Georgiou-Karistianis, N. (2022). Longitudinal mapping of cortical surface changes in Huntington’s Disease. Brain Imaging and Behavior, 16(3), 1381–1391. https://doi.org/10.1007/s11682-021-00625- 2eng
dcterms.referencesTan, B., Shishegar, R., Poudel, G. R., Fornito, A., & Georgiou-Karistianis, N. (2021). Cortical morphometry and neural dysfunction in Huntington’s disease: a review. European Journal of Neurology, 28(4), 1406–1419. https://doi.org/https://doi.org/10.1111/ene.14648eng
dcterms.referencesTishkoff, S. A., & Kidd, K. K. (2004). Implications of biogeography of human populations for “race” and medicine. Nature Genetics, 36(11 Suppl), S21-7. https://doi.org/10.1038/ng1438eng
dcterms.referencesTröster, A. I., Pulaski, S. J., & Woods, S. P. (2019). Neuropsychology of movement disorders and motor neuron disease: Parkinson’s disease, progressive supranuclear palsy, essential tremor, Huntington’s disease, and amyotrophic lateral sclerosis. In Handbook of medical neuropsychology: Applications of cognitive neuroscience, 2nd ed. (pp. 415–440). Springer Nature Switzerland AG. https://doi.org/10.1007/978-3- 030-14895-9_19eng
dcterms.referencesUniversidad Simón Bolivar. (2021). Enfermedad de Huntington una aproximación desde la investigación.spa
dcterms.referencesValdés Hernández, M. D. C., Abu-Hussain, J., Qiu, X., Priller, J., Parra Rodríguez, M., Pino, M., Báez, S., & Ibáñez, A. (2019). Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington’s disease. Brain and Behavior, 9(8), e01343. https://doi.org/10.1002/brb3.1343eng
dcterms.referencesVaportzis, E., Georgiou-Karistianis, N., Churchyard, A., & Stout, J. C. (2015). Dual task performance in Huntington’s disease: A comparison of choice reaction time tasks. Neuropsychology, 29(5), 703–712. https://doi.org/10.1037/neu0000172eng
dcterms.referencesVonsattel, J. P., & DiFiglia, M. (1998). Huntington disease. Journal of Neuropathology and Experimental Neurology, 57(5), 369–384. https://doi.org/10.1097/00005072- 199805000-00001eng
dcterms.referencesWalker, R. H., Gatto, E. M., Bustamante, M. L., Bernal-Pacheco, O., Cardoso, F., Castilhos, R. M., Chana-Cuevas, P., Cornejo-Olivas, M., Estrada-Bellmann, I., & Jardim, L. B. (2018). Huntington’s disease-like disorders in Latin America and the Caribbean. Parkinsonism & Related Disorders, 53, 10–20.eng
dcterms.referencesWarby, S. C., Visscher, H., Collins, J. A., Doty, C. N., Carter, C., Butland, S. L., Hayden, A. R., Kanazawa, I., Ross, C. J., & Hayden, M. R. (2011). HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. European Journal of Human Genetics, 19(5), 561–566. https://doi.org/10.1038/ejhg.2010.229eng
dcterms.referenceswikiwand. (n.d.). Diáspora vasca. Https://Assets.Wikiwand.Com/Img/Logo_new.Svgeng
dcterms.referencesWilson, H., Dervenoulas, G., & Politis, M. (2018). Chapter Nine - Structural Magnetic Resonance Imaging in Huntington’s Disease. In M. Politis (Ed.), Imaging in Movement Disorders: Imaging in Atypical Parkinsonism and Familial Movement Disorders (Vol. 142, pp. 335–380). Academic Press. https://doi.org/https://doi.org/10.1016/bs.irn.2018.09.006eng
dcterms.referencesWolf, R. C., Sambataro, F., Vasic, N., Baldas, E.-M., Ratheiser, I., Bernhard Landwehrmeyer, G., Depping, M. S., Thomann, P. A., Sprengelmeyer, R., Süssmuth, S. D., & Orth, M. (2014). Visual system integrity and cognition in early Huntington’s disease. The European Journal of Neuroscience, 40(2), 2417–2426. https://doi.org/10.1111/ejn.12575eng
dcterms.referencesYeterian, E. H., & Pandya, D. N. (1995). Corticostriatal connections of extrastriate visual areas in rhesus monkeys. The Journal of Comparative Neurology, 352(3), 436–457. https://doi.org/10.1002/cne.903520309eng
dcterms.referencesYoun, Y. C., Pyun, J.-M., Ryu, N., Baek, M. J., Jang, J.-W., Park, Y. H., Ahn, S.-W., Shin, H.-W., Park, K.-Y., & Kim, S. Y. (2021). Use of the Clock Drawing Test and the Rey–Osterrieth Complex Figure Test-copy with convolutional neural networks to predict cognitive impairment. Alzheimer’s Research & Therapy, 13(1), 85. https://doi.org/10.1186/s13195-021-00821-8eng
dcterms.referencesZaitlen, N., Kraft, P., Patterson, N., Pasaniuc, B., Bhatia, G., Pollack, S., & Price, A. L. (2013). Using Extended Genealogy to Estimate Components of Heritability for 23 Quantitative and Dichotomous Traits. PLoS Genetics, 9(5). https://doi.org/10.1371/journal.pgen.1003520eng
dcterms.referencesZeun, P., Scahill, R. I., Tabrizi, S. J., & Wild, E. J. (2019). Fluid and imaging biomarkers for Huntington’s disease. Molecular and Cellular Neuroscience, 97, 67–80. https://doi.org/https://doi.org/10.1016/j.mcn.2019.02.004eng
dcterms.referencesZivelin, A., Bauduer, F., Ducout, L., Peretz, H., Rosenberg, N., Yatuv, R., & Seligsohn, U. (2002). Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood, 99(7), 2448–2454. https://doi.org/10.1182/blood.V99.7.2448eng
dcterms.referencesE. M. & A. R. Daza B, Caiaffa RH, Arteta BJV, Echevarría RV, “Estudio neuroepidemiológico enJuandeAcosta,Atlántico,Colombia,” ActaMédCoI, vol. 17, p. 324, 1991.spa
oaire.versioninfo:eu-repo/semantics/acceptedVersion
sb.programaDoctorado en Genética y Biología Molecular
sb.sedeSede Barranquilla

Archivos

Bloque original
Mostrando 1 - 2 de 2
No hay miniatura disponible
Nombre:
PDF.pdf
Tamaño:
2.21 MB
Formato:
Adobe Portable Document Format
Cargando...
Miniatura
Nombre:
PDF_Resumen.pdf
Tamaño:
311.75 KB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones